Torrent Pharmaceuticals Limited Issues Voluntary Nationwide Recall of Losartan Potassium Tablets, USP
Torrent Pharmaceuticals Limited is voluntarily recalling 2 lots of Losartan potassium tablets, USP
to the consumer level due to the detection of trace amounts of an
unexpected impurity found in an active pharmaceutical ingredient (API)
manufactured by Hetero Labs Limited. The impurity detected in the API is
N-nitrosodiethylamine (NDEA), which is a substance that occurs
naturally in certain foods, drinking water, air pollution, and
industrial processes, and has been classified as a probable human
carcinogen as per International Agency for Research on Cancer (IARC)
classification.More info at Recalls Global
No comments:
Post a Comment